Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128452) titled 'A retrospective multi-center clinical study on clinical characteristics and prognostic factors of childhood lymphoma' on July 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital, Sun Yat-sen University
Condition:
Hodgkin lymphoma, Non-Hodgkin lymphoma
Intervention:
Rituximab treatment group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-14
Target Sample Size: Rituximab treatment group:150;Chemotherapy-Only Group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...